AMERICAN SHARED HOSPITAL SERVICES Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $2.89 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-04-04
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $2.93.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2016-03-31 was $1.90.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $2.89, a 6.25% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $2.72, a 6.85% decline from fiscal 2021.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $2.92, a 55.32% increase from fiscal 2020.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2020 was $1.88, a 34.49% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.89 10-K · filed 2025-04-04 | |||
| 2023-09-30 | $2.82 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $2.82 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $2.93 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $2.72 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $2.72 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $2.92 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $2.92 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $2.92 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $1.88 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $1.88 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $1.88 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $2.87 10-K · filed 2021-04-06 | |||
| 2019-09-30 | $2.91 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $2.91 10-Q · filed 2020-08-14 | |||
| 2018-12-31 | $2.68 10-K · filed 2020-04-03 | |||
| 2018-09-30 | $2.68 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $2.68 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $3.31 10-K · filed 2019-03-29 | |||
| 2016-12-31 | $2.19 10-K · filed 2017-03-27 | |||
| 2016-09-30 | $2.19 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | $2.19 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | $1.90 10-Q · filed 2016-05-12 | |||
| 2015-12-31 | $2.48 10-K · filed 2016-03-30 | |||
| 2015-09-30 | $2.48 10-Q · filed 2015-11-12 | |||
| 2015-06-30 | $2.58 10-Q · filed 2015-08-19 | |||
| 2014-12-31 | $2.89 10-K · filed 2015-04-01 | |||
| 2013-12-31 | $2.23 10-K · filed 2014-03-31 | |||
| 2012-12-31 | $3.05 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |